CD4 and dermatomyositis: Routine blood tests and clinical manifestations revealed that CD3+CD4+ T cell levels and the development of hypoxemia at the beginning of the disease were positively correlated with mortality in patients with anti-MDA5 antibody-positive dermatomyositis, which may indicate a poor prognosis.